Postoperative Comput Tomography as a Predictor of Postoperative Complications After Pancreatic Surgery
NCT ID: NCT02814812
Last Updated: 2026-01-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2014-01-31
2018-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pancreaticoduodenectomies With Complete Arterial Coverage by Retromesenteric Omentoplasty
NCT05992857
Pancreatic Stump Closure After Distal Pancreatic Resection
NCT02113046
Chyle Leak After Pancreatic Operation
NCT03127150
Predictors of Severity of Postoperative Pancreatic Fistula After Pancreatoduodenectomy
NCT05291923
Risk Factors for Postoperative Pancreatic Fistula Following Non-traumatic Pancreatic Surgery. Retrospective Observational Study.
NCT05711433
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pancreatic surgery
CT scan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CT scan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having an indication of pancreatic surgery
* In scheduled surgery
* Agreeing to participate in the research (ie who signed the informed consent to research participation)
* \>18yo
Exclusion Criteria
* With emergency surgery
* Protected by law
* Under 18 years
* Presenting an against-indications to the scanner: documented severe allergy to contrast material, kidney failure against-showing the contrast medium injection, pregnancy, lactation and/or MRI (pacemaker, metallic intraocular foreign body)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CHU de Reims
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Reims
Reims, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Durot C, Rousset P, Thivolet A, Passot G, Deguelte S, Dohan A, Glehen O, Hoeffel C. What the radiologist should know about postoperative MDCT evaluation of a patient treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy. Clin Radiol. 2018 Jun;73(6):517-525. doi: 10.1016/j.crad.2018.02.001. Epub 2018 Mar 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PO14086
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.